Identity
- Security key
- 12037
- Ticker
- ATTO
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-08-05
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ATTO
Detail
Enriched 2026-08-14 20:47
- Market cap
- —
- Shares outstanding (class)
- —
- Shares outstanding (weighted)
- —
- SIC
- —
- Employees
- —
- Location
- —
- Homepage
- https://www.attovia.com
- Description
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
Market cap and share counts drift.